Anzeige
Mehr »
Mittwoch, 11.03.2026 - Börsentäglich über 12.000 News
Die nächsten 10.000 Bohrmeter könnten alles verändern, während andere Explorer noch planen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
511 Leser
Artikel bewerten:
(2)

Response Plus Medical (RPM): Response Plus Medical announces strategic acquisition of UK-based Prometheus as part of global expansion plans

  • Prometheus Medical is a UK-based healthcare training and consultancy services company; specializing in combat medicine and emergency response
  • Extends RPM offering into UK-Nordic region and strengthen capabilities for Energy and Defense sector
  • RPM obtains distributorship for Safeguard Medical trauma care products across GCC and India

MUMBAI, India and LONDON , Jan. 22, 2024 /PRNewswire/ -- In a step towards becoming one of the largest global pre-hospital services providers, Response Plus Medical (RPM) has announced the strategic acquisition of UK-headquartered Prometheus Medical, a well-respected healthcare training and consultancy services company. Prometheus is part of Safeguard Medical, a global provider of innovative emergency medical technologies and specialized training for first responders.

RPM Logo (PRNewsfoto/Response Plus Medical (RPM))

RPM is part of Response Plus Holding PJSC, the largest pre-hospital medical services provider in the UAE and KSA, listed on the Abu Dhabi Securities Exchange. Prometheus focuses on equipping combat service providers and emergency responders with training and consultancy services, empowering emergency service personnel since 2005. This acquisition brings together two leading healthcare providers forming a credible Global healthcare platform for Energy and Defense companies.

Presently, RPM operates 500 clinics catering to the oil & gas and industrial sectors, boasting a tier-one client roster that includes prominent names such as ADNOC, Schlumberger, Oxy, TOTAL, and Halliburton. Prometheus acquisition will provide opportunity to extend its coverage to Global Oil majors and reputed Defense provider serviced by Prometheus, including Shell, Chevron, ACKER BP, DCAS, the United Kingdom's Military and Royal Flight of Oman, and the UK Security, Defense and NHS emergency services.

By acquiring the UK company, RPM is set to strengthen its training capabilities, while expanding the company's portfolio to cover health consultancy for emergency preparedness and response. The acquisition also accelerates RPM's market entry into the UK and Nordic region. Integration of the two companies will offer one stop solutions for offering emergency consultancy and training services, remote health (including emergency) services tailored to needs of Energy and Defense companies, VIPs medical coverage, and other health needs.

Dr. Rohil Raghavan, CEO of Response Plus Medical, reinforced the importance of this acquisition in implementing the company's global expansion strategy. He said, "The strategic acquisition of Prometheus not only enhances our capability to deliver top-tier healthcare services to valued clients in diverse and innovative fields but also expands our global footprint. This move further solidifies our position as the preferred healthcare provider for leading energy and defense entities worldwide. We eagerly anticipate integrating Prometheus's expertise into our offerings as part of our ongoing mission to deliver exceptional healthcare solutions."

As part of the acquisition, RPM will become a distributor for US-based Safeguard Medical's innovative trauma care and simulation products in GCC and India, bringing the most advanced range of trauma products to the region.

Steven Wines, President of Training and Consultancy at Prometheus Medical, said, "This is a pivotal moment for both organizations, paving the way for an integrated healthcare solutions provider encompassing pre-hospital services and specialized training and consultancy services. Our track record and diverse specialties, including Pre-hospital Care Protocols, Helicopter Emergency Medical Service, International Major Incident Management, and innovative medical training, position us as key contributors to this transformative partnership. We are poised to deliver exceptional and cutting-edge healthcare solutions that transcend boundaries and elevate standards across industries."

Following the acquisition, RPM is pursuing a robust strategy of integrating all aspects of pre-hospital healthcare services under one umbrella. The acquisition is planned to be funded through a combination of debt and internal accruals, and estimated to contribute early teen inorganic revenue and EBITDA growth to RPM on a run-rate basis.

About RPM

Founded in 2010, Response Plus Holding is the largest provider of onsite healthcare, medical emergency services and occupational health solutions in the UAE. RPM was listed as Response Plus Holding PJSC on the Abu Dhabi Securities Exchange in 2021 and is also currently listed on the FTSE GEIS as a global micro-cap company. Boasting the largest medical vehicle fleet in the region with 426 ambulances, RPM has become a trusted name and a partner of choice in its field of operation. It has conducted more than 1.2 million training sessions for healthcare and non- healthcare professionals, performed over 10,000 helicopter medical emergency evacuations, and offers reliable medical support for major sporting events in the region.

About Safeguard Medical

Safeguard Medical is home to trusted brands for emergency medical product technologies and skills training. Offering a powerful portfolio of innovative, high-quality products, simulation capabilities, training courses and consultancy programs, Safeguard Medical is dedicated to advancing its mission of equipping and enabling responders at every skill level to preserve life in any environment. Driven by innovation and real-world experience, Safeguard Medical aims to solve not only the emergency medical needs of today, but to prepare for the demands of tomorrow. For more information, visit www.safeguardmedical.com.

Photo: https://mma.prnewswire.com/media/2323321/Response_Plus_Medical.jpg
Logo: https://mma.prnewswire.com/media/2323320/RPM_Logo.jpg

(Left to Right) Mr. Adam Johnson, CEO of Safeguard Medical & Dr. Rohil Raghavan, CEO Response Plus Medical. (PRNewsfoto/Response Plus Medical (RPM))

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/response-plus-medical-announces-strategic-acquisition-of-uk-based-prometheus-as-part-of-global-expansion-plans-302040418.html

© 2024 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.